← FDA DRUG APPROVALS

FDA ANDA · ANDA070171

NALOXONE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA070171
TYPE
ANDA
ORIGINAL APPROVAL
2004-07-29
LATEST ACTION
2004-07-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NALOXONE HYDROCHLORIDEDiscontinued
NALOXONE HYDROCHLORIDE 0.02MG/ML · INJECTABLE · INJECTION

Approval history

2004-07-29OriginalAP
2001-02-14Manufacturing (CMC) · Supplement 4AP
1995-12-22Manufacturing (CMC) · Supplement 3AP
1993-04-26Manufacturing (CMC) · Supplement 2AP
1992-11-19Labeling · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →